Gilmour et al. [29] reported that therapeutic targeting of Neu1 with OP upended pancreatic cancer growth and metastatic spread in heterotopic xenografts of MiaPaCa-2-eGFP tumors growing in RAGxCγ double mutant mice. The gene discussed is NEU1; the disease is familial pancreatic carcinoma.